The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

Abstract Background Chemotherapy‐induced toxicities frequently occur in non‐small cell lung cancer (NSCLC) patients treated with platinum‐based chemotherapy. Low skeletal muscle mass (SMM) has been associated with a higher incidence of toxicities for several types of cancers and cytostatics. The aim...

Full description

Bibliographic Details
Main Authors: Corine deJong, Najiba Chargi, Gerarda J.M. Herder, Simone W.A. vanHaarlem, Femke van derMeer, Anne S.R. vanLindert, Alexandra tenHeuvel, Jan Brouwer, Pim A. deJong, Lot A. Devriese, Alwin D.R. Huitema, Toine C.G. Egberts, Remco deBree, Vera H.M. Deneer
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Non‐small cell lung cancer
Body composition
Skeletal muscle mass
Platinum‐based chemotherapy
Chemotherapy‐induced toxicity
Online Access:https://doi.org/10.1002/jcsm.12967

Internet

https://doi.org/10.1002/jcsm.12967

Similar Items